Skip to main content

Table 3 Treatment and outcome

From: Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore

Variable

Completed (n = 108)

Re-admitted (n = 12)

p-value

Laboratory findings (initial)

 WBC, ×109/L

10.4 (7.8–12.9)

11.0 (9.1–12.4)

0.66

 C-reactive protein, mg/L

21.8 (8–50)

74 (17–147)

0.17

Laboratory findings (end of treatment)

 WBC, ×109/L

7.7 (6.3–9.0)

9.1 (7.4–10.9)

0.21

 C-reactive protein, mg/L

3.2 (1.3–6.7)

10.1 (1.9–22.5)

0.14

IV antibiotics used

 Duration of IV antibiotics, days

3 (3–3)

3 (3–3)

0.54

 Cefazolin

77 (71.3)

8 (66.7)

0.74

 Ceftriaxone

31 (28.7)

4 (33.3)

NA

PO antibiotics used

 Duration of PO antibiotics, days

7 (7–7)

7 (6–12)

0.26

  1. For categorical variables, data was presented in frequencies and percentages. Fisher’s exact test was used to test for association
  2. For continuous variables, data was presented in median and interquartile range. Mann-Whitney test was used to test for differences